Description
BPC-157 & TB-500 Blend 20mg – Research Peptide Blend
BPC-157 & TB-500 Blend 20mg is a research-grade peptide formulation supplied for controlled laboratory investigation involving peptide signaling, extracellular matrix biology, and cellular pathway analysis.
This formulation contains two peptides frequently referenced in scientific literature:
• BPC-157 – 10mg
• TB-500 (Thymosin Beta-4) – 10mg
Both peptides have appeared in experimental research examining molecular pathways related to connective tissue biology, cellular signaling systems, and peptide-mediated biochemical processes.
The combined format allows researchers to investigate these peptides within controlled laboratory models examining peptide interactions and signaling pathways.
BPC-157 & TB-500 Blend 20mg is supplied strictly for in-vitro laboratory research and analytical investigation. This compound is not approved for human or veterinary use.
What Is BPC-157 & TB-500 Blend?
This research formulation combines two peptides commonly referenced in experimental literature.
BPC-157 (10mg)
BPC-157 is a synthetic peptide fragment derived from a protein sequence associated with gastric peptides.
Scientific literature referencing BPC-157 has examined experimental models involving:
• Peptide signaling within connective tissue research models
• Nitric oxide–related molecular pathways
• Angiogenesis-associated signaling systems
• Cellular pathway analysis related to extracellular matrix biology
These topics remain areas of ongoing laboratory investigation.
TB-500 (Thymosin Beta-4) – 10mg
TB-500 is a synthetic peptide related to Thymosin Beta-4, a naturally occurring peptide present in multiple tissue types.
Research literature referencing Thymosin Beta-4–related peptides has examined laboratory models involving:
• Actin regulation within cellular systems
• Cellular migration signaling pathways
• Angiogenesis-related molecular signaling
• Peptide activity within musculoskeletal research models
These areas continue to be subjects of experimental investigation.
Areas of Scientific Investigation
Research literature referencing BPC-157 and TB-500 has examined laboratory models involving:
• Peptide signaling pathways within connective tissue research
• Angiogenesis-associated molecular pathway analysis
• Cellular signaling systems related to extracellular matrix biology
• Peptide-receptor interaction studies
• Musculoskeletal cellular research models
These references are provided for informational context regarding the compounds’ presence in scientific research.
Laboratory Research Contexts
Researchers may investigate the BPC-157 & TB-500 Blend within experimental frameworks such as:
• Peptide interaction studies
• Molecular signaling pathway analysis
• Extracellular matrix and connective tissue research models
• Cellular peptide signaling investigations
• Peptide structure and stability studies
BPC-157 & TB-500 Blend 20mg – Research Supply Specifications
• Multi-peptide research formulation
• Total peptide content: 20mg lyophilized powder
• Composition: 10mg BPC-157 + 10mg TB-500
• Analytical purity standard: 99%+
• Third-party laboratory testing for identity and purity
• Manufactured under controlled quality standards
• Canada-based fulfillment
• Batch-level quality verification
Purity & Quality Assurance
ExoLabz provides research peptides manufactured to high analytical standards. Each batch of BPC-157 & TB-500 Blend undergoes independent third-party testing to verify peptide identity and purity.
Researchers may conduct additional analytical verification if required for laboratory use. If validated testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.
Important Legal Notice
For Research Purposes Only
BPC-157 & TB-500 Blend 20mg is supplied strictly for laboratory research and analytical use.
This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.
This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.
By purchasing this product, the buyer confirms that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Chang CH, et al. J Appl Physiol. 2011;110(3):774-780. In rat Achilles tendon explant culture and isolated tendon fibroblasts, measured explant outgrowth, fibroblast survival under oxidative stress, migration, and FAK/paxillin phosphorylation. Source · PMID 21030672
- Hsieh MJ, et al. J Mol Med (Berl). 2017;95(3):323-333. In chick chorioallantoic membrane assay, a rat hind-limb ischaemia model and human endothelial cell culture, measured vessel density, endothelial tube formation and VEGFR2-Akt-eNOS phosphorylation. Source · PMID 27847966
- Chang CH, et al. Molecules. 2014;19(11):19066-19077. In primary tendon fibroblasts from Sprague-Dawley rat Achilles tendon, measured growth hormone receptor mRNA and protein levels, PCNA expression and JAK2 phosphorylation. Source · PMID 25415472
- Bock-Marquette I, et al. Nature. 2004;432(7016):466-472. In embryonic mouse cardiomyocyte and endothelial culture and a mouse coronary artery ligation model, measured cell migration, myocyte survival and ILK/Akt kinase activity. Source · PMID 15565145
- Malinda KM, et al. FASEB J. 1997;11(6):474-481. In human umbilical vein endothelial cell (HUVEC) culture, measured directional chemotactic migration in Boyden-chamber assays. Source · PMID 9194528
- Philp D, et al. FASEB J. 2003;17(14):2103-2105. In HUVEC culture and chick aortic arch explants, measured migration, adhesion and vessel sprouting elicited by the LKKTETQ actin-binding motif at approximately 50 nM. Source · PMID 14500546
Literature notes: The published base for this compound is small and concentrated in a limited number of research groups, with little independent replication of in vivo findings. Published work concerns full-length thymosin beta-4 or its LKKTETQ actin-binding fragment. Equivalence between those and material marketed as TB-500 is not established in the literature.
Related Research Compounds
Browse more compounds in Regenerative Peptides, or view the full research peptide catalogue.
